Hillhouse Capital Management (Hillhouse) recently increased their stake in Hong Kong-listed AK Medical Holdings. According to a filing submitted to the Hong Kong Stock Exchange on September 13th, 2019, Hillhouse bought 50,000,000 shares via a placing agreement at an average price of HKD 7.01 per share on September 10th (the total consideration was ~US$44.8m). As a result of the purchase, Hillhouse now has a 7.26% stake in AK Medical Holdings. You can view the company’s announcement regarding the transaction here.

AK Medical Holdings is a medical device company that has commercialized the application of 3D-printing technology in orthopedic joint and spine replacement implants in China. The company designs, develops, produces and markets orthopedic implants, with a particular focus on hip and knee replacement implants.

Hillhouse is a leading investment management firm. They invest with a long-term time horizon and employ a fundamental, bottom-up approach. They focus on the consumer, TMT, industrials and healthcare sectors and invest in companies across all equity stages. The firm was founded by Lei Zhang in 2005 with backing from the Yale Endowment.